Literature DB >> 14612975

Immunohistochemical expression of metalloproteinases MMP-2 and MMP-9 in abdominal aortic aneurysms: correlation with symptoms and aortic diameter.

Efstathios Papalambros1, Fragiska Sigala, Sotiris Georgopoulos, Charalambos Menekakos, Alexandra Giatromanolaki, Elias Bastounis, Efthymios Sivridis.   

Abstract

Our purpose was to investigate the expression of matrix metalloproteinase (MMP)-2 and -9 in all types of abdominal aortic aneurysms (AAA): symptomatic, asymptomatic, and ruptured. MMP-2 and -9 activity was investigated in surgical samples from the arterior wall of 46 AAA, using a standard immunohistochemical technique. The MMP-9 activity was significantly higher in large AAA (>6 cm), but there was no relation between AAA size and MMP-2 activity. Neither MMP-2 nor MMP-9 were related with AAA rupture, other complications or symptoms. The MMP-9 activity in AAA is a determinant of the aneurysm size, but it is not related to clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612975

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  10 in total

1.  mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease.

Authors:  S Soumian; R Gibbs; A Davies; C Albrecht
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

2.  The role of lysyl oxidase family members in the stabilization of abdominal aortic aneurysms.

Authors:  Ebony Washington Remus; Robert E O'Donnell; Kathryn Rafferty; Daiana Weiss; Giji Joseph; Katalin Csiszar; Sheri F T Fong; W Robert Taylor
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

3.  Matrix metalloproteinase levels in chronic thoracic aortic dissection.

Authors:  Xiaoming Zhang; Darrell Wu; Justin C Choi; Charles G Minard; Xinguo Hou; Joseph S Coselli; Ying H Shen; Scott A LeMaire
Journal:  J Surg Res       Date:  2014-03-19       Impact factor: 2.192

4.  A novel arterial pouch model of saccular aneurysm by concomitant elastase and collagenase digestion.

Authors:  Xin-jian Yang; Li Li; Zhong-xue Wu
Journal:  J Zhejiang Univ Sci B       Date:  2007-10       Impact factor: 3.066

5.  Aortic pseudoaneurysm formation following concurrent chemoradiotherapy and metallic stent insertion in a patient with esophageal cancer.

Authors:  Pei-Yu Hou; Chung-Jen Teng; Chen-Shuan Chung; Chao-Yu Liu; Chun-Chieh Huang; Miu-Hsiang Chang; Pei-Wei Shueng; Chen-Hsi Hsieh
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

6.  Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms.

Authors:  Batmunkh Bumdelger; Hiroki Kokubo; Ryo Kamata; Masayuki Fujii; Koichi Yoshimura; Hiroki Aoki; Yuichi Orita; Takafumi Ishida; Megu Ohtaki; Masataka Nagao; Mari Ishida; Masao Yoshizumi
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

Review 7.  Effect of Acupuncture on the p38 Signaling Pathway in Several Nervous System Diseases: A Systematic Review.

Authors:  Tzu-Hsuan Wei; Ching-Liang Hsieh
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

8.  Exploring smooth muscle phenotype and function in a bioreactor model of abdominal aortic aneurysm.

Authors:  Kirsten Riches; Timothy G Angelini; Gurprit S Mudhar; Jean Kaye; Emily Clark; Marc A Bailey; Soroush Sohrabi; Sotirios Korossis; Peter G Walker; D Julian A Scott; Karen E Porter
Journal:  J Transl Med       Date:  2013-09-12       Impact factor: 5.531

9.  Up-regulated MCPIP1 in abdominal aortic aneurysm is associated with vascular smooth muscle cell apoptosis and MMPs production.

Authors:  Ming Xue; Gang Li; Dan Li; Zhu Wang; Lei Mi; Jingjing Da; Xing Jin
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

Review 10.  Nanomaterials as Promising Theranostic Tools in Nanomedicine and Their Applications in Clinical Disease Diagnosis and Treatment.

Authors:  Wei Zhu; Zhanqi Wei; Chang Han; Xisheng Weng
Journal:  Nanomaterials (Basel)       Date:  2021-12-10       Impact factor: 5.076

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.